Return to Publications  |  Return to CINJ Home
Rutgers Cancer Institute of New Jersey's Cancer Connection, November 2014
Donate NowThe latest news on research, treatment, prevention and education from the
state's only National Cancer Institute-designated Comprehensive Cancer Center
Exploring an Investigational Treatment for a Rare Type of Skin Cancer



Rutgers Cancer Institute of New Jersey is one of 50 global sites to offer a clinical trial examining an investigational treatment for a rare type of skin cancer known as Merkel cell carcinoma. Led by Howard Kaufman, MD, FACS, associate director for clinical science and chief surgical officer at the Cancer Institute of New Jersey and professor of surgery at Rutgers Robert Wood Johnson Medical School, the study focuses on the impact of the drug on the immune system and its ability to combat cancer cells.Learn more

$5.7 Million Grant Expands African-American Breast Cancer Study



A $5.7 million grant from the National Institutes of Health will enable investigators at Rutgers Cancer Institute of New Jersey, Rutgers School of Public Health and Roswell Park Cancer Institute to expand their research of breast cancer in African-American women by exploring the impact of obesity and other health factors on survival and quality of life. The aim of the study is to increase the understanding of the biological pathways underlying the relationship between obesity, comorbidities, and poorer disease prognosis.Learn more

Rutgers Cancer Institute Research Could Have Implications for Colorectal Cancer



Uncovering the mechanisms of a protein activator involved in promoting colorectal cancer, Rutgers Cancer Institute of New Jersey scientists have demonstrated that a small GTPase enzyme, known as Rab1A, is a key switch for amino acid signaling - a process investigators say could play a role in targeted cancer therapy. Cancer Institute researcher X.F. Steven Zheng, PhD, university professor of pharmacology at Rutgers Robert Wood Johnson Medical School, is the senior author of the research published in the latest edition of Cancer Cell.Learn more

Helping Those with Blood Cancers


blood match

Every four minutes someone is diagnosed with a form of blood cancer in the United States. During this National Marrow Awareness Month, Rutgers Cancer Institute of New Jersey hematologist/ oncologist Vimal Patel, MD, who is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, shares some information on how you can help save or improve the quality of life for those with leukemia, lymphoma, myeloma, and other forms of the disease.Learn more

Partnering for Good Lung Health


lung screen

To promote early detection of lung cancer, Rutgers Cancer Institute of New Jersey, in collaboration with Robert Wood Johnson University Hospital, Rutgers Robert Wood Johnson Medical School and University Radiology are providing a low-cost lung cancer screening program for those at high risk for developing the disease. If you are a smoker or former smoker over age 50, you may be eligible. For information or to make an appointment, call 732-235-5947.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List